investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Nathanael S Gray
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Nathanael S Gray
Dana-Farber Cancer Institute
Boston, United States
Subrahmanyam Vangala
Sai Advantium Pharma Ltd.
Pune, India
Related projects
Bing Xu
Enzyme-instructed self-assembly for molecular anticancer nanomedicines
Melanoma of skin
Edward Seto
The Basic and Translational Implication of SIRT1 and DNMT1 in Cancer
Melanoma of skin
Zena Werb
Role of Metalloproteinases in Mammary Gland Remodeling
Breast
Areti Strati
Molecular Characterization of CTC in Prostate Cancer
Breast
Michael Gottesman
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
Melanoma of skin
Antonio Fojo
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
Breast
Pier Paolo Pandolfi
PTEN in ontogenesis and tumor suppression
Breast
Isaac Brownell
Clinical Treatment of Advanced Merkel Cell Carcinoma
Melanoma of skin
Pathology
Mikhail Nikiforov
KLF9-TXNRD2 axis in melanoma progression and metastasis
Melanoma of skin